
Brandon Folkes
Stock Analyst at H.C. Wainwright
(0.24)
# 4,695
Out of 5,162 analysts
561
Total ratings
36.7%
Success rate
-4%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: GNFT Genfit S.A. | Reiterated: Buy | €23.00 | €10.54 | +118.22% | 1 | Nov 18, 2026 | |
| RNTX Rein Therapeutics | Reiterated: Buy | $8 | $0.3677 | +2,075.69% | 11 | Nov 18, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $0.6282 | +1,014.29% | 23 | Nov 17, 2026 | |
| ENTA Enanta Pharmaceuticals | Reiterated: Buy | $20 | $7.98 | +150.63% | 14 | Nov 17, 2026 | |
| OMER Omeros | Reiterated: Buy | $33 | $14.01 | +135.55% | 28 | Nov 17, 2026 | |
| TRAW Traws Pharma | Reiterated: Hold | $1 | $0.23 | +334.78% | 6 | Nov 17, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $8 → $6 | $0.3993 | +1,402.63% | 18 | Nov 16, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $29 | $9.62 | +201.46% | 15 | Nov 16, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Reiterated: Buy | $12.85 | $1.25 | +927.71% | 16 | Nov 16, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $22.89 | $8.78 | +160.72% | 23 | Nov 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $9.07 | +186.66% | 18 | Nov 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.08 | +155.91% | 15 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.55 | +266.20% | 12 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.2641 | - | 41 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $6.99 | +758.37% | 9 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.739 | +305.95% | 22 | Nov 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.55 | +98.47% | 13 | Nov 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.87 | +104.43% | 1 | Nov 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $13.72 | +74.93% | 16 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $18 | $16.62 | +8.30% | 10 | Nov 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 | $69.13 | +75.03% | 25 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $25.21 | +138.00% | 43 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.95 | +153.16% | 27 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.5806 | +1,794.59% | 13 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.37 | +235.51% | 10 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.18 | +747.46% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $28.35 | +69.31% | 1 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $6.26 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $5.15 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $1.90 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $0.81 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 → $33 | $0.65 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $15 | $2.11 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $282.73 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $40 | $0.3233 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.0003 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $50 | $0.0005 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $46.18 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $56.35 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $236.45 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $8 | $0.000001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $32.67 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $12 | - | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $23.75 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $34.08 | n/a | 2 | Sep 12, 2016 |
Genfit S.A.
Nov 18, 2026
Reiterated: Buy
Price Target: €23.00
Current: €10.54
Upside: +118.22%
Rein Therapeutics
Nov 18, 2026
Reiterated: Buy
Price Target: $8
Current: $0.3677
Upside: +2,075.69%
Connect Biopharma Holdings
Nov 17, 2026
Reiterated: Buy
Price Target: $7
Current: $0.6282
Upside: +1,014.29%
Enanta Pharmaceuticals
Nov 17, 2026
Reiterated: Buy
Price Target: $20
Current: $7.98
Upside: +150.63%
Omeros
Nov 17, 2026
Reiterated: Buy
Price Target: $33
Current: $14.01
Upside: +135.55%
Traws Pharma
Nov 17, 2026
Reiterated: Hold
Price Target: $1
Current: $0.23
Upside: +334.78%
Milestone Pharmaceuticals
Nov 16, 2026
Reiterated: Buy
Price Target: $8 → $6
Current: $0.3993
Upside: +1,402.63%
Sagimet Biosciences
Nov 16, 2026
Reiterated: Buy
Price Target: $29
Current: $9.62
Upside: +201.46%
Cardiol Therapeutics Inc.
Nov 16, 2026
Reiterated: Buy
Price Target: $12.85
Current: $1.25
Upside: +927.71%
Eupraxia Pharmaceuticals Inc.
Nov 16, 2026
Reiterated: Buy
Price Target: $22.89
Current: $8.78
Upside: +160.72%
Nov 16, 2026
Reiterated: Buy
Price Target: $26
Current: $9.07
Upside: +186.66%
Nov 13, 2026
Reiterated: Buy
Price Target: $13
Current: $5.08
Upside: +155.91%
Nov 13, 2026
Reiterated: Buy
Price Target: $13
Current: $3.55
Upside: +266.20%
Nov 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.2641
Upside: -
Nov 13, 2026
Reiterated: Buy
Price Target: $60
Current: $6.99
Upside: +758.37%
Nov 13, 2026
Reiterated: Buy
Price Target: $3
Current: $0.739
Upside: +305.95%
Nov 12, 2026
Reiterated: Buy
Price Target: $13
Current: $6.55
Upside: +98.47%
Nov 11, 2026
Reiterated: Buy
Price Target: $12
Current: $5.87
Upside: +104.43%
Nov 10, 2026
Reiterated: Buy
Price Target: $24
Current: $13.72
Upside: +74.93%
Nov 9, 2026
Rated: Buy
Price Target: $10 → $18
Current: $16.62
Upside: +8.30%
Nov 6, 2026
Reiterated: Buy
Price Target: $121
Current: $69.13
Upside: +75.03%
Nov 6, 2026
Reiterated: Buy
Price Target: $60
Current: $25.21
Upside: +138.00%
Nov 6, 2026
Reiterated: Buy
Price Target: $10
Current: $3.95
Upside: +153.16%
Oct 6, 2026
Reiterated: Buy
Price Target: $11
Current: $0.5806
Upside: +1,794.59%
Sep 21, 2026
Reiterated: Buy
Price Target: $18
Current: $5.37
Upside: +235.51%
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.18
Upside: +747.46%
Aug 4, 2026
Reiterated: Buy
Price Target: $48
Current: $28.35
Upside: +69.31%
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $6.26
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $5.15
Upside: n/a
May 3, 2024
Reiterated: Buy
Price Target: $3 → $4
Current: $1.90
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $20 → $10
Current: $0.81
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 13, 2023
Reiterated: Hold
Price Target: $37 → $33
Current: $0.65
Upside: n/a
Feb 9, 2023
Reiterated: Buy
Price Target: $22 → $15
Current: $2.11
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $282.73
Upside: n/a
Nov 22, 2022
Reiterated: Buy
Price Target: $22 → $40
Current: $0.3233
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.0003
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $5 → $50
Current: $0.0005
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $46.18
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $56.35
Upside: n/a
Oct 6, 2021
Reiterated: Buy
Price Target: $210
Current: $236.45
Upside: n/a
Aug 9, 2021
Reiterated: Buy
Price Target: $6 → $8
Current: $0.000001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $32.67
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $18 → $12
Current: -
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $23.75
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $34.08
Upside: n/a